186 related articles for article (PubMed ID: 5736846)
1. [Use of desferal and some data on hemosiderosis in hypo- and aplastic anemias].
Fainshtein FE; Trubina NS; Sobaleva IuG; Rozanova NS; Voronina AN
Probl Gematol Pereliv Krovi; 1968 Aug; 13(8):31-8. PubMed ID: 5736846
[No Abstract] [Full Text] [Related]
2. Desferal therapy in iron storage disease.
Thompson RB; Owen DM; Bell WN
Am J Med Sci; 1967 Apr; 253(4):453-60. PubMed ID: 6021380
[No Abstract] [Full Text] [Related]
3. [Use of desferal in treatment of sideroses of different origin. (Literature review)].
Turbina NS
Probl Gematol Pereliv Krovi; 1968 Jul; 13(7):47-52. PubMed ID: 4898933
[No Abstract] [Full Text] [Related]
4. [Desferrioxamine in patients with hemochromatosis and hemosiderosis].
Maspes V; Tamigaki M; Gomes ZJ; Jamra M
Rev Hosp Clin Fac Med Sao Paulo; 1966; 21(4):181-95. PubMed ID: 5918167
[No Abstract] [Full Text] [Related]
5. Congenital erythroblastic hypoplasia. Treatment of transfusion hemosiderosis with desferrioxamine B.
Hildner FJ; Monto RW; Rebuck JW
Henry Ford Hosp Med J; 1968; 16(2):147-55. PubMed ID: 5650037
[No Abstract] [Full Text] [Related]
6. [Further experiences with iron-chelating therapy (desferrioxamine and ascorbic acid) in siderochromatosis and Cooley's disease].
Cartei G; Cazzavillan M; Chisesi T; Battista R; Barbui T; Dini E
Minerva Med; 1978 Mar; 69(13):811-21. PubMed ID: 643223
[No Abstract] [Full Text] [Related]
7. [Use of desferal in anemia, myeloid leukemia and other pathological conditions].
Kol'tsova GN; Meshchanov AIu
Gematol Transfuziol; 1992; 37(9-10):44-6. PubMed ID: 1490576
[No Abstract] [Full Text] [Related]
8. [Use of desferrioxamine B in normal subjects and in patients with increased iron storage].
Muranda M; Velasco M; Giménez E; Ruiz J; Bastías E; Rodriguez J; Etcheverry R; Guzmán C; Regonesi C; Janklevich S
Rev Med Chil; 1965 Apr; 93(4):127-33. PubMed ID: 5832943
[No Abstract] [Full Text] [Related]
9. [A new iron chelating agent: desferrioxamine B (Desferal). Clinico-pharmacological observations. Cases].
Gallinelli R; Coppini D
Minerva Med; 1965 Nov; 56(92):3980-5. PubMed ID: 5845686
[No Abstract] [Full Text] [Related]
10. [Erythroblastic aplasia in an adolescent].
Fleury J; Soulier JP; de Menibus CH; Hazard E
Nouv Rev Fr Hematol; 1970; 10(5):583-96. PubMed ID: 4250281
[No Abstract] [Full Text] [Related]
11. The treatment of hemosiderosis in thalassaemia major with desferrioxamine-B.
Kirimlidis S; Philippidis P; Drossos C; Economidis J
Helv Paediatr Acta; 1966 Sep; 21(4):343-50. PubMed ID: 5997620
[No Abstract] [Full Text] [Related]
12. [Continuous subcutaneous desferrioxamine infusions in patients with hemosiderosis (author's transl)].
Tillmann W; König R; Schröder K; Schröter W
Monatsschr Kinderheilkd; 1982 Mar; 130(3):171-2. PubMed ID: 7087975
[No Abstract] [Full Text] [Related]
13. [Treatment of primary idiopathic hemochromatosis and secondary hemosiderosis].
Strohmeyer G
Dtsch Med Wochenschr; 1974 Nov; 99(45):2295-9. PubMed ID: 4448138
[No Abstract] [Full Text] [Related]
14. [Desferal treatment of hemosiderosis in hemoglobinopathies (based on records from Kuveit)].
Khutsishvili GE
Ter Arkh; 1971 Oct; 43(10):98-101. PubMed ID: 4258785
[No Abstract] [Full Text] [Related]
15. [Long-term efficacy of subcutaneous administration of deferoxamine in patients with secondary hemochromatosis].
Kobayashi M; Yano K; Fujisawa S
Rinsho Ketsueki; 1996 Apr; 37(4):303-10. PubMed ID: 8847800
[TBL] [Abstract][Full Text] [Related]
16. Iron chelation in acute iron poisoning and chronic hypersiderosis.
Walsh JR; Gillick JB
Clin Pediatr (Phila); 1965 Nov; 4(11):633-8. PubMed ID: 5844429
[No Abstract] [Full Text] [Related]
17. [Current status of treatments with desferrioxamine B in post-transfusion hypersiderosis in children].
Orsini A; Raybaud C; Bernard PJ; Aquaron R; Passeron P
Mars Med; 1967; 104(4):331-7. PubMed ID: 5621537
[No Abstract] [Full Text] [Related]
18. [Deferoxamine-B, a ferriuretic chelate].
Dyerberg J
Ugeskr Laeger; 1967 Sep; 129(36):1135-9. PubMed ID: 4880917
[No Abstract] [Full Text] [Related]
19. Iron overload in cardiac valvular disease and pure red cell aplasia: treatment with desferrioxamine.
Hehlmann R; Schmitz H; Krüger K
Int J Cardiol; 1984 Jun; 5(6):749-53. PubMed ID: 6235195
[TBL] [Abstract][Full Text] [Related]
20. [Study of a case of idiopathic pulmonary hemosiderosis treated with an iron chelating agent (desferoxamine B, "Desferal")].
Poggio GL; Lucioni F
Minerva Med; 1967 Sep; 58(70):2985-93. PubMed ID: 6054090
[No Abstract] [Full Text] [Related]
[Next] [New Search]